The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International
Abstract
The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report Belpomme, Dominique, George L. Carlo, Philippe Irigaray, David O. Carpenter, Lennart Hardell, Michael Kundi, Igor Belyaev, Magda Havas, Franz Adlkofer, Gunnar Heuser, Anthony B. Miller, Daniela Caccamo, Chiara De Luca, Lebrecht von Klitzing, Martin L. Pall, Priyanka Bandara, Yael Stein, Cindy Sage, Morando Soffritti, Devra Davis, Joel M. Moskowitz, S. M.J. Mortazavi, Martha R. Herbert, Hanns Moshammer, Gerard Ledoigt, Robert Turner, Anthony Tweedale, Pilar Muñoz-Calero, Iris Udasin, Tarmo Koppel, Ernesto Burgio, and André Vander Vorst. 2021. "The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report" International Journal of Molecular Sciences 22(14):7321. doi:10.3390/ijms22147321. Abstract Clinical research aiming at objectively identifying and characterizing diseases via clinical observations and biological and radiological findings is a critical initial research step when establishing objective diagnostic criteria and treatments. Failure to first define such diagnostic criteria may lead research on pathogenesis and etiology to serious confounding biases and erroneous medical interpretations. This is particularly the case for electrohypersensitivity (EHS) and more particularly for the so-called “provocation tests”, which do not investigate the causal origin of EHS but rather the EHS-associated particular environmental intolerance state with hypersensitivity to man-made electromagnetic fields (EMF). However, because those tests depend on multiple EMF-associated physical and biological parameters and have been conducted in patients without having first defined EHS objectively and/or endpoints adequately, they cannot presently be considered to be valid pathogenesis research methodologies. Consequently, the negative results obtained by these tests do not preclude a role of EMF exposure as a symptomatic trigger in EHS patients. Moreover, there is no proof that EHS symptoms or EHS itself are caused by psychosomatic or nocebo effects. This international consensus report pleads for the acknowledgement of EHS as a distinct neuropathological disorder and for its inclusion in the WHO International Classification of Diseases. : mdpi.com
AI evidence extraction
Main findings
The report argues that EMF provocation tests have methodological limitations (e.g., multiple EMF-associated parameters and inadequate objective definition/endpoints for EHS) and that negative provocation-test results do not preclude EMF exposure as a symptomatic trigger in EHS patients. It states there is no proof that EHS symptoms or EHS itself are caused by psychosomatic or nocebo effects, and calls for recognition of EHS as a distinct neuropathological disorder and inclusion in the WHO ICD.
Outcomes measured
- Electrohypersensitivity (EHS) diagnostic characterization
- Molecular biomarkers (proposed/advocated)
- Imaging/radiological findings (proposed/advocated)
- Interpretation/validity of EMF provocation tests
- Role of EMF exposure as symptomatic trigger in EHS
- Psychosomatic/nocebo explanations (discussed)
- Policy/classification: inclusion of EHS in WHO International Classification of Diseases
Limitations
- No specific study design details
- participant selection
- or sample size are provided in the abstract
- No specific biomarker/imaging endpoints or quantitative results are reported in the abstract
- Exposure characteristics (frequency
- intensity/SAR
- duration
- source types) are not specified
Suggested hubs
- who-icnirp (0.7)Calls for inclusion of EHS in the WHO International Classification of Diseases (WHO ICD).
View raw extracted JSON
{
"study_type": "review",
"exposure": {
"band": null,
"source": "man-made electromagnetic fields (EMF)",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Patients with electrohypersensitivity (EHS) (discussed)",
"sample_size": null,
"outcomes": [
"Electrohypersensitivity (EHS) diagnostic characterization",
"Molecular biomarkers (proposed/advocated)",
"Imaging/radiological findings (proposed/advocated)",
"Interpretation/validity of EMF provocation tests",
"Role of EMF exposure as symptomatic trigger in EHS",
"Psychosomatic/nocebo explanations (discussed)",
"Policy/classification: inclusion of EHS in WHO International Classification of Diseases"
],
"main_findings": "The report argues that EMF provocation tests have methodological limitations (e.g., multiple EMF-associated parameters and inadequate objective definition/endpoints for EHS) and that negative provocation-test results do not preclude EMF exposure as a symptomatic trigger in EHS patients. It states there is no proof that EHS symptoms or EHS itself are caused by psychosomatic or nocebo effects, and calls for recognition of EHS as a distinct neuropathological disorder and inclusion in the WHO ICD.",
"effect_direction": "unclear",
"limitations": [
"No specific study design details, participant selection, or sample size are provided in the abstract",
"No specific biomarker/imaging endpoints or quantitative results are reported in the abstract",
"Exposure characteristics (frequency, intensity/SAR, duration, source types) are not specified"
],
"evidence_strength": "insufficient",
"confidence": 0.74,
"peer_reviewed_likely": "yes",
"keywords": [
"electrohypersensitivity",
"EHS",
"biomarkers",
"imaging",
"provocation tests",
"environmental intolerance",
"man-made electromagnetic fields",
"nocebo",
"psychosomatic",
"WHO International Classification of Diseases",
"consensus report"
],
"suggested_hubs": [
{
"slug": "who-icnirp",
"weight": 0.6,
"reason": "Calls for inclusion of EHS in the WHO International Classification of Diseases (WHO ICD)."
}
]
}AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.
NNEMF synthesis
Synthesis pending.